Sort
23,748 grants matching “melanoma”
Dendritics Cell Immunotherapy for Colorectal Cancer
$288,476Lawrence Fong · University Of California, San Francisco · R01 · FY2007 · CA
Enhancing antitumor immunity with anti-PD-1 antibody in follicular lymphoma.
$288,425Sattva S Neelapu · University Of Tx Md Anderson Can Ctr · R21 · FY2010 · CA
Project 1: Targeted sequencing and clinicopathology to evaluate primary melanoma molecular subtypes and outcomes
$288,413Marianne Berwick · University Of New Mexico Health Scis Ctr · P01 · FY2019 · CA
Generation of Anti-Melanoma T Cells Derived from Human Embryonic Stem Cells
$288,409Jerome A. Zack · California Institute Of Technology · P01 · FY2013 · CA
Gene Discovery in Melanoma Etiology
$288,392Timothy R Rebbeck · Wistar Institute · P50 · FY2008 · CA
Validation of genomic targets in melanoma
$288,354Mohammed Kashani-Sabet · University Of California, San Francisco · R01 · FY2008 · CA
Mimimal-Perturbation Dynamic Control of the Melanoma Gene Regulatory Network
$288,350Dan Schonfeld · University Of Illinois At Chicago · R01 · FY2011 · GM
MECHANISMS OF ALCOHOL RELATED INHIBITION OF NK ACTIVITY
$288,332Washington State University · R01 · FY2002 · AA
Personal tumor neoantigens for immunity against chronic lymphocytic leukemia
$288,332Catherine Ju-Ying Wu · Dana-Farber Cancer Inst · R01 · FY2014 · CA
Manipulation of Tumor Specific Immunity
$288,325Hans Schreiber · University Of Chicago · R01 · FY2016 · CA
Manipulation of Tumor Specific Immunity
$288,325Hans Schreiber · University Of Chicago · R01 · FY2018 · CA
Manipulation of Tumor Specific Immunity
$288,325Hans Schreiber · University Of Chicago · R01 · FY2017 · CA
Project 4
$288,300Eva Hernando · New York University School Of Medicine · P50 · FY2020 · CA
Combination immunotherapies for the treatment of melanoma
$288,300Michael W Fanger · Celdara Medical, Llc · R43 · FY2013 · CA
optimized Human Apyrase for Bone Cancer Pain Treatment
$288,298Ridong Chen · Apt Therapeutics, Inc. · R43 · FY2013 · CA
Artificial Immune Moduating (AIM??)Platform for the Treatment of Cancer
$288,268Bruce J McCreedy · Neximmune, Inc. · R43 · FY2013 · CA
High-Grade Astrocytoma-Specific Molecular Targeting
$288,259Waldemar Debinski · Wake Forest University Health Sciences · R01 · FY2019 · CA
PRETARGETING STRATEGIES FOR CENTRAL NERVOUS MALIGNANCY RADIOIMMUNOTHERAPY
$288,255Duke University · P50 · FY2001 · NS
PRETARGETING STRATEGIES FOR CENTRAL NERVOUS MALIGNANCY RADIOIMMUNOTHERAPY
$288,255Duke University · P50 · FY2000 · NS
Regulation of RANKL Expression in T-Lymphocytes
$288,212Yufang Shi · Univ Of Med/Dent Nj-R W Johnson Med Sch · P01 · FY2008 · AI
Role of DeltaNp63alpha in Vitamin D Mediated Cell Survival in Skin Cancer
$288,184Madhavi P Kadakia · Wright State University · R01 · FY2012 · CA
Mechanism and Inhibition of Collagenolytic Activity
$288,155Gregg B Fields · University Of Texas Hlth Science Center · R01 · FY2010 · CA
Novel Immuno-oncology Strategy for Targeted Cytotoxic Lymphocyte Activation
$288,105Alexander Sasha Krupnick · Courier Therapeutics, Inc. · R41 · FY2018 · CA
Roles of Glycoconjugates and Redox Signaling in Tumor Biology
$288,086David D Roberts · Division Of Clinical Sciences - Nci · Z01 · FY2008 · CA
Role of Immune Regulatory Pathways in BRAF targeted therapy In melanoma
$288,077Arlene H Sharpe · University Of Tx Md Anderson Can Ctr · U54 · FY2014 · CA